Form 15-15D YD Biopharma Ltd

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 15

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number: 333-283428-01

 

YD BIOPHARMA LIMITED

(Exact name of registrant as specified in its charter)

 

12F., No. 3, Xingnan St.,

Nangang Dist.,

Taipei City 115001, Taiwan

+(886) 2382-0330

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Ordinary shares, par value $0.10 per share

(Title of each class of securities covered by this Form)

 

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1)		☒
Rule 12g-4(a)(2)		☐
Rule 12h-3(b)(1)(i)		☒
Rule 12h-3(b)(1)(ii)		☐
Rule 15d-6		☐
Rule 15d-22(b)		☐

 

Approximate number of holders of record as of the certification or notice date: One

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, YD Biopharma Limited has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

	YD Biopharma Limited
Date: September 8, 2025
	By:	/s/ Ethan Shen
	Name:	Ethan Shen
	Title:	Chief Executive Officer

 

 

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Carahsoft Named 2026 Authorized Distribution Partner of the Year by Arctic Wolf
• Flight Attendant Alleges Billionaire Peter Thiel's Husband, Matt Danzeisen, Violently Assaulted Her Aboard Private Jet, Then Sued First to Silence Her. Suit Filed by HHJ Trial Attorneys, a Southern Ca
• Empower AI Acquires Highlight Technologies to Accelerate AI-Driven Mission Delivery Across Federal Agencies